Literature DB >> 9659873

Gabapentin as a potential treatment for anxiety disorders.

M H Pollack, J Matthews, E L Scott.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9659873     DOI: 10.1176/ajp.155.7.992

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  28 in total

1.  Gabapentin in the Treatment of Posttraumatic Stress Disorder.

Authors:  Timothy R. Berigan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-06

2.  Psychiatric Uses of Newer Anticonvulsants.

Authors:  Timothy R. Berigan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-04

Review 3.  Antiepileptic drugs for the treatment of post-traumatic stress disorder.

Authors:  Heather A Berlin
Journal:  Curr Psychiatry Rep       Date:  2007-08       Impact factor: 5.285

Review 4.  HCN Channel Targets for Novel Antidepressant Treatment.

Authors:  Stacy M Ku; Ming-Hu Han
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

5.  Gabapentin completely attenuated the acute morphine induced c-Fos expression in the rat striatum.

Authors:  Jamil Ahsan Kazi; Chen Fun Gee
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

Review 6.  Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations.

Authors:  Catherine C Crone; Geoffrey M Gabriel
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

7.  GABA(A)R plasticity during pregnancy: relevance to postpartum depression.

Authors:  Jamie Maguire; Istvan Mody
Journal:  Neuron       Date:  2008-07-31       Impact factor: 17.173

8.  Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin.

Authors:  Barbara J Mason; John M Light; Lauren D Williams; David J Drobes
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

Review 9.  Targeting voltage-gated calcium channels for neuropathic pain management.

Authors:  Danielle Perret; Z David Luo
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

10.  Gabapentin enacarbil - clinical efficacy in restless legs syndrome.

Authors:  Pinky Agarwal; Alida Griffith; Henry R Costantino; Narendra Vaish
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.